NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 42 filers reported holding NEOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $211,000 | -84.9% | 337,188 | -87.2% | 0.00% | – |
Q3 2020 | $1,396,000 | -23.0% | 2,631,585 | -0.6% | 0.00% | -100.0% |
Q2 2020 | $1,813,000 | -6.7% | 2,647,219 | +2.1% | 0.00% | 0.0% |
Q1 2020 | $1,944,000 | -49.7% | 2,592,072 | +1.3% | 0.00% | 0.0% |
Q4 2019 | $3,865,000 | +7.8% | 2,559,374 | +5.6% | 0.00% | 0.0% |
Q3 2019 | $3,587,000 | +13.9% | 2,423,515 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $3,149,000 | -2.2% | 2,441,181 | +97.8% | 0.00% | 0.0% |
Q1 2019 | $3,221,000 | +456.3% | 1,234,014 | +251.9% | 0.00% | – |
Q4 2018 | $579,000 | +283.4% | 350,690 | +1029.3% | 0.00% | – |
Q3 2018 | $151,000 | -62.1% | 31,054 | -51.2% | 0.00% | – |
Q2 2018 | $398,000 | +44.7% | 63,628 | +92.0% | 0.00% | – |
Q1 2018 | $275,000 | -24.5% | 33,135 | -7.0% | 0.00% | – |
Q4 2017 | $364,000 | +267.7% | 35,641 | +136.1% | 0.00% | – |
Q3 2016 | $99,000 | -10.0% | 15,094 | +26.8% | 0.00% | – |
Q2 2016 | $110,000 | -51.5% | 11,905 | +10.0% | 0.00% | – |
Q3 2015 | $227,000 | – | 10,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,962,657 | $3,100,000 | 2.37% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $62,000 | 0.02% |
SlateStone Wealth, LLC | 62,000 | $39,000 | 0.01% |
Allred Capital Management, LLC | 24,995 | $15,000 | 0.01% |
Bridge Advisory, LLC | 23,564 | $15,000 | 0.01% |
Livingston Group Asset Management CO (operating as Southport Capital Management) | 24,000 | $15,000 | 0.01% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 320,993 | $201,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 229,500 | $143,000 | 0.00% |
Virtu Financial LLC | 41,401 | $26,000 | 0.00% |
TSFG, LLC | 200 | $1,000 | 0.00% |